Publisher Correction: Sirt1 activator induces proangiogenic genes in preadipocytes to rescue insulin resistance in diet-induced obese mice

Correction to: Scientific Reports 10.1038/s41598-018-29773-0, published online 27 July 2018

This Article contains an error in Figure 3E, where the HFD+SRT1720 label is missing. The correct Figure 3 appears below as Figure 1.

Figure 1.

SRT1720 treatment enhances vasculature in eWAT. (A) mRNA expression of genes related to angiogenesis in eWAT. (n = 6–7). The results are shown as the mean ± SEM. *P < 0.05, **P < 0.01. (B) Immunostaining of eWAT with anti-CD31 and CD34 antibody. (C) Immunofluorescence labeling of eWAT with anti-PDGFRb. (D) Immunofluorescence labeling of eWAT with anti-CD31 (green) and anti-CD13 (red) antibodies. Scale bar, 100 μm. (E) Relative mRNA expression of hypoxia-related genes in eWAT from DIO mice treated with or without SRT1720 (n = 4–5 per group). The results are shown as the mean ± SEM. *P < 0.05, **P < 0.01.